Datastream
Why Investors Are Psyched About Psychedelic Stocks
The Briefing
- Plenty of psychedelic stocks have experienced triple-digit returns in the last year
- Optimism is brewing as governments grant research approvals for the study of psychedelics on mental health
- By some estimates, the psychedelic drugs market is projected to see compound annual growth (CAGR) of 16.3% to reach $6.85 billion by 2027
Psyched About Psychedelics
Psychedelic stocks are trading like biotechnology companies these days. The prospect of promising research has pushed valuations upwards. And like biotech companies, they often report no revenues and are a volatile bunch.
Awareness around mental health disorders is increasing, as are the number of people who suffer from them—a figure exacerbated by the pandemic. Although these factors are grim, they are actually catalysts for psychedelic stocks.
The Societal Cost
Today, greater emphasis is put towards combating mental health. In part because its societal cost is increasingly difficult to ignore. And the solutions to them may take on various forms. For instance, alternative medication.
There are over 100 million people who are resistant to traditional treatments for depression. Some studies reveal up to ⅓ of patients experience treatment-resistant depression.
As a result, this is where the application of psychedelics in microdoses is perceived to add value—and where a market may arise.
Regulatory Status
1. Health Canada
Health Canada granted 16 exemptions to a selection of nurses, doctors, therapists and social workers. Thus, allowing them to possess and use psilocybin for personal training without fear of prosecution under the country’s drug laws.
2. The FDA
The FDA declared psychedelics a breakthrough therapy for severe depression.
3. The State of Oregon
Oregon approves a legal framework for the therapeutic use of psilocybin. Becoming the first state to do so.
Mushrooming Valuations
Investors love a good story. And legalizing psychedelic drugs to combat the growing societal challenge that is mental health is as good as it gets.
Psychedelic Stock | 2020 Stock Price Performance |
---|---|
Mind Medicine | 864% |
Numinus Wellness | 555% |
Red Light Holland | 300% |
Codebase Ventures | 210% |
Revive Therapeutics | 166% |
Hollister Biosciences | 148% |
Lobe Sciences | 133% |
Compass Pathways | 88% |
Better Plant Sciences | 76% |
Some of the earlier research and studies on psychedelics are expected to be released by mid-2021, and investors are already getting ahead of this in optimistic anticipation. This is evident in the valuations of some of these companies, which in some cases are already reaching a billion dollars.
Welcome to the shroom boom.
Where does this data come from?
Source:YCharts & Frontiers In Psychology
Notes: This data was released on September 4, 2020
Datastream
Charted: The Ukraine War Civilian Death Toll
Using data from the UN, this chart shows civilian death toll figures resulting from Russia’s invasion of Ukraine.

The Briefing
- In total, since the war began in February there have been over 7,031 Ukrainian civilian deaths
- Most of the civilian casualties recorded were caused by the use of explosive weapons, such as missiles and heavy artillery
Charted: The Ukraine War Civilian Death Toll
Russia’s war of aggression in Ukraine has wrought suffering and death on a mass scale, with many Russian attacks targeted at civilians.
We’ve created this visual using data from the UN Office of the High Commissioner for Human Rights (OHCHR) to better understand how many civilians have died in Ukraine as a result of the war, as well as how many were injured and how many were children.
The Numbers
As of early December, it is reported that 7,031 people in Ukraine have died because of the war — 433 of them children. Another 11,327 have been injured, 827 of which are children. In total, this is over 18,000 people killed or injured.
The figures are difficult to verify due to differing reports coming out of both Russia and Ukraine. The UN OHCHR anticipates that the numbers could be even higher.
The State of the Conflict
The war began on February 24th, 2022 and less than a year in, millions of people have been displaced by the conflict, and thousands of civilians have been injured or killed.
According to the UN, most of the civilian deaths have been caused by wide-ranging explosives such as heavy artillery shelling, missiles, and air strikes, and have been concentrated in Donetsk and Luhansk and in other territory still held by Ukraine.
Additionally, new estimates from Kyiv report approximately 13,000 Ukrainian military or soldier deaths, which has yet to be confirmed by the army.
Where does this data come from?
Source: The United Nations Office of the High Commissioner for Human Rights monthly reports on civilian deaths in Ukraine.
Note: Data on deaths and injuries can vary wildly depending on the source.
-
Misc4 days ago
Visualizing the Odds of Dying from Various Accidents
-
Energy2 weeks ago
The Periodic Table of Commodity Returns (2013-2022)
-
Technology2 days ago
Infographic: 11 Tech Trends to Watch in 2023
-
Misc4 weeks ago
Infographic: The Longest Lasting Cars, in Miles
-
Politics2 weeks ago
Which Countries are the Most Polarized?
-
Energy13 hours ago
Visualizing the Scale of Global Fossil Fuel Production
-
Markets4 weeks ago
The U.S. Stock Market: Best and Worst Performing Sectors in 2022
-
Energy2 weeks ago
Visualizing China’s Dominance in Battery Manufacturing (2022-2027P)